Our Offering
Biologics
Mammalian
Microbial
ADCs / Bioconjugates
Drug Product
mRNA / LNP
Expression Technologies
Small Molecules
Drug Substance (API)
Particle Engineering
Drug Product
Cell & Gene
Process Development
cGMP manufacturing
Allogeneic
Autologous
Viral Vectors
Bioscience Products
Capsules & Health Ingredients
Pharmaceutical Solutions
Nutraceutical Solutions
Our Company
About Us
Purpose and Strategy
Leadership
History
Locations
Site Tours
Partnering with Us
Events
News and Media
News Releases
Images and Videos
Logo Guidelines
Blog
Podcast
Journalist Inquiries
Investor Relations
Shareholder Information
Agenda and Events
Financial Reporting
Annual Report
Corporate Governance
Ethics and Compliance
Investor Inquiries
Sustainability
Performance
People
Planet
Community
Global Quality
Responsible Sourcing
Careers
Overview
Life at Lonza
What We Offer
Career Stories
Job Search
Join Our Talent Community
Recruitment Process
Students, Graduates and Apprentices
Contact
Our Offering
Corporate
Biologics
Mammalian
Microbial
ADCs / Bioconjugates
Drug Product
mRNA / LNP
Expression Technologies
Small Molecules
Drug Substance (API)
Particle Engineering
Drug Product
Cell & Gene
Process Development
cGMP manufacturing
Allogeneic
Autologous
Viral Vectors
Bioscience Products
Capsules & Health Ingredients
Pharmaceutical Solutions
Nutraceutical Solutions
Our Company
Corporate
About Us
Purpose and Strategy
Leadership
History
Locations
Site Tours
Partnering with Us
Events
News and Media
News Releases
Images and Videos
Logo Guidelines
Blog
Podcast
Journalist Inquiries
Investor Relations
Shareholder Information
Agenda and Events
Financial Reporting
Annual Report
Corporate Governance
Ethics and Compliance
Investor Inquiries
Sustainability
Performance
People
Planet
Community
Global Quality
Responsible Sourcing
Careers
Corporate
Overview
Life at Lonza
What We Offer
Career Stories
Job Search
Join Our Talent Community
Recruitment Process
Students, Graduates and Apprentices
Contact
Corporate
Home
Knowledge Center
Connecting Clinic and Commercial Biopharma Manufacturing
06 Sep 2021
Connecting Clinic and Commercial Biopharma Manufacturing
You may also be interested in:
Mammalian
Commercial Supply Services
Manufacturing: GMP Drug Substance
Manufacturing: GMP Drug Product
Watch this video
Watch now
Latest content
Latest briefing from the Knowledge Center
Webinar (on-demand)
Solving Bispecific Antibody Heavy-Light Chain Mispairing with bYlok® Technology
Lonza’s bYlok® bispecific pairing technology is an innovative solution that drives correct...
Video
How Does bYlok® Technology Work and How Can It Improve Bispecific Production?
Bispecific antibodies offer numerous potential clinical benefits, and the number of bispecifics in...
Webinar (on-demand)
PBPK Modeling for Identifying and Mitigating Absorption Risks in Early Drug Development
When coupled with in vitro measurements, PBPK modeling is effective in early development for 1)...
White paper
The Early Advantage for IND Success and Beyond
Many of the decisions made during the early days of building and compiling the manufacturing...
Interview
Q&A: Why Use GS piggyBac® Transposase Technology for Expression of Your Biotherapeutics?
Article
Tackling Complexity: From Molecule to Formulation
Presentation (slides)
Optimizing GMP Manufacturing of Lipid Nanoparticles
Lonza is now offering next-generation encapsulation of nucleic acids with FDmiX. In this...
Article
Q&A: How to Maximise Cell Line Productivity and Efficiency
In this interview, Dr. Tabitha Bullock, a principal group leader at Lonza, tells us about some...
Presentation (on-demand)
Lonza Bend Capabilities
At Lonza's facility in Bend (OR), our core capabilities include bioavailability enhancement,...
Technical/Service brief
Oral Multiparticulate Technologies
Multiparticulates offer a number of advantages, including optimized GI tract distribution,...
Poster
Extracellular Vesicles: Engineering New Therapeutic Delivery Modalities
Extracellular Vesicles (EVs), including exosomes, are emerging as promising natural nano-scale...
Poster
Plasmid Engineering to Improve AAV Productivity and Packaging Efficiency
The packaging efficiency (full to total capsid ratio, or F/T ratio) for Adeno-Associated Virus (AAV)...
Previous
Next